These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 10551435)

  • 1. Treatment and prevention of multidrug-resistant tuberculosis.
    Bastian I; Colebunders R
    Drugs; 1999 Oct; 58(4):633-61. PubMed ID: 10551435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of multidrug-resistant tuberculosis in Thailand.
    Maranetra KN
    Chemotherapy; 1996; 42 Suppl 3():10-5; discussion 30-3. PubMed ID: 8980862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model.
    Atun RA; Lebcir R; Drobniewski F; Coker RJ
    Int J STD AIDS; 2005 Aug; 16(8):560-70. PubMed ID: 16105192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directly observed treatment, short-course strategy and multidrug-resistant tuberculosis: are any modifications required?
    Bastian I; Rigouts L; Van Deun A; Portaels F
    Bull World Health Organ; 2000; 78(2):238-51. PubMed ID: 10743297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance profile and risk factors of drug resistant tuberculosis in the Baltic countries.
    Ignatyeva O; Balabanova Y; Nikolayevskyy V; Koshkarova E; Radiulyte B; Davidaviciene E; Riekstina V; Jaama K; Danilovits M; Popa CM; Drobniewski FA
    Tuberculosis (Edinb); 2015 Sep; 95(5):581-8. PubMed ID: 26164355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
    Yew WW
    Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study.
    Leimane V; Riekstina V; Holtz TH; Zarovska E; Skripconoka V; Thorpe LE; Laserson KF; Wells CD
    Lancet; 2005 Jan 22-28; 365(9456):318-26. PubMed ID: 15664227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a comprehensive programme to provide universal access to care for sputum-smear-positive multidrug-resistant tuberculosis in China: a before-and-after study.
    Li R; Ruan Y; Sun Q; Wang X; Chen M; Zhang H; Zhao Y; Zhao J; Chen C; Xu C; Su W; Pang Y; Cheng J; Chi J; Wang Q; Fu Y; Huan S; Wang L; Wang Y; Chin DP
    Lancet Glob Health; 2015 Apr; 3(4):e217-28. PubMed ID: 25794675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Infection Control Measures to Control an Outbreak of Multidrug-Resistant Tuberculosis in a Human Immunodeficiency Virus Ward, Peru.
    Ticona E; Huaroto L; Kirwan DE; Chumpitaz M; Munayco CV; Maguiña M; Tovar MA; Evans CA; Escombe R; Gilman RH
    Am J Trop Med Hyg; 2016 Dec; 95(6):1247-1256. PubMed ID: 27621303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistant tuberculosis.
    Riley LW
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S442-6. PubMed ID: 8274610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Exogenous re-infection in tuberculosis].
    Tsuchiya T
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India.
    D'souza DT; Mistry NF; Vira TS; Dholakia Y; Hoffner S; Pasvol G; Nicol M; Wilkinson RJ
    BMC Public Health; 2009 Jun; 9():211. PubMed ID: 19563647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features, diagnosis, and management of multiple drug-resistant tuberculosis since 2002.
    Drobniewski F; Balabanova Y; Coker R
    Curr Opin Pulm Med; 2004 May; 10(3):211-7. PubMed ID: 15071373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
    Chang KC; Yew WW
    Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
    Centers for Disease Control and Prevention
    MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort Study.
    Grandjean L; Gilman RH; Martin L; Soto E; Castro B; Lopez S; Coronel J; Castillo E; Alarcon V; Lopez V; San Miguel A; Quispe N; Asencios L; Dye C; Moore DA
    PLoS Med; 2015 Jun; 12(6):e1001843; discussion e1001843. PubMed ID: 26103620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant tuberculosis management in resource-limited settings.
    Nathanson E; Lambregts-van Weezenbeek C; Rich ML; Gupta R; Bayona J; Blöndal K; Caminero JA; Cegielski JP; Danilovits M; Espinal MA; Hollo V; Jaramillo E; Leimane V; Mitnick CD; Mukherjee JS; Nunn P; Pasechnikov A; Tupasi T; Wells C; Raviglione MC
    Emerg Infect Dis; 2006 Sep; 12(9):1389-97. PubMed ID: 17073088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular tools for rapid identification and novel effective therapy against MDRTB/XDRTB infections.
    Viveiros M; Martins M; Couto I; Rodrigues L; Machado D; Portugal I; Amaral L
    Expert Rev Anti Infect Ther; 2010 Apr; 8(4):465-80. PubMed ID: 20377340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.